Bio-Rad Laboratories Net Profit Margin 2010-2023 | BIO.B
Current and historical net profit margin for Bio-Rad Laboratories (BIO.B) from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue. Bio-Rad Laboratories net profit margin for the three months ending March 31, 2023 was .
Bio-Rad Laboratories Net Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Net Income |
Net Margin |
2023-03-31 |
$2.78B |
$-0.19B |
-6.87% |
2022-12-31 |
$2.80B |
$-3.63B |
-129.44% |
2022-09-30 |
$2.81B |
$-6.02B |
-214.72% |
2022-06-30 |
$2.87B |
$-1.93B |
-67.26% |
2022-03-31 |
$2.90B |
$-0.09B |
-3.11% |
2021-12-31 |
$2.92B |
$4.25B |
145.54% |
2021-09-30 |
$2.98B |
$6.67B |
223.69% |
2021-06-30 |
$2.88B |
$4.05B |
140.73% |
2021-03-31 |
$2.70B |
$4.11B |
151.98% |
2020-12-31 |
$2.55B |
$3.81B |
149.80% |
2020-09-30 |
$2.38B |
$3.52B |
147.90% |
2020-06-30 |
$2.29B |
$1.95B |
84.83% |
2020-03-31 |
$2.33B |
$1.58B |
67.77% |
2019-12-31 |
$2.31B |
$1.76B |
76.04% |
2019-09-30 |
$2.31B |
$0.38B |
16.31% |
2019-06-30 |
$2.29B |
$0.90B |
39.49% |
2019-03-31 |
$2.29B |
$0.57B |
25.00% |
2018-12-31 |
$2.29B |
$0.37B |
15.94% |
2018-09-30 |
$2.29B |
$1.28B |
55.67% |
2018-06-30 |
$2.28B |
$1.03B |
45.12% |
2018-03-31 |
$2.21B |
$0.77B |
34.67% |
2017-12-31 |
$2.16B |
$0.12B |
5.65% |
2017-09-30 |
$2.11B |
$0.02B |
0.76% |
2017-06-30 |
$2.09B |
$0.01B |
0.58% |
2017-03-31 |
$2.10B |
$0.03B |
1.19% |
2016-12-31 |
$2.07B |
$0.03B |
1.21% |
2016-09-30 |
$2.07B |
$0.09B |
4.55% |
2016-06-30 |
$2.03B |
$0.09B |
4.58% |
2016-03-31 |
$2.02B |
$0.10B |
5.10% |
2015-12-31 |
$2.02B |
$0.11B |
5.40% |
2015-09-30 |
$2.05B |
$0.10B |
4.98% |
2015-06-30 |
$2.11B |
$0.10B |
4.60% |
2015-03-31 |
$2.14B |
$0.10B |
4.72% |
2014-12-31 |
$2.18B |
$0.09B |
4.14% |
2014-09-30 |
$2.18B |
$0.08B |
3.72% |
2014-06-30 |
$2.15B |
$0.06B |
2.88% |
2014-03-31 |
$2.14B |
$0.07B |
3.03% |
2013-12-31 |
$2.13B |
$0.08B |
3.66% |
2013-09-30 |
$2.10B |
$0.09B |
4.33% |
2013-06-30 |
$2.10B |
$0.14B |
6.72% |
2013-03-31 |
$2.08B |
$0.15B |
7.39% |
2012-12-31 |
$2.07B |
$0.17B |
7.97% |
2012-09-30 |
$2.05B |
$0.18B |
8.90% |
2012-06-30 |
$2.06B |
$0.19B |
8.97% |
2012-03-31 |
$2.08B |
$0.18B |
8.53% |
2011-12-31 |
$2.07B |
$0.18B |
8.63% |
2011-09-30 |
$2.06B |
$0.19B |
9.09% |
2011-06-30 |
$2.01B |
$0.19B |
9.24% |
2011-03-31 |
$1.96B |
$0.18B |
9.39% |
2010-12-31 |
$1.93B |
$0.19B |
9.65% |
2010-09-30 |
$1.89B |
$0.16B |
8.26% |
2010-06-30 |
$1.88B |
$0.15B |
7.99% |
2010-03-31 |
$1.84B |
$0.15B |
8.17% |
2009-12-31 |
$1.78B |
$0.15B |
8.13% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$10.988B |
$2.802B |
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
|